References

Clinical and laboratory features in anti-NF155 autoimmune nodopathy

10.1212/nxi.0000000000001098. · 2021 · External reference

European academy of neurology/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision

10.1111/ene.14959 · 2021 · External reference

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy

10.1002/ana.23794 · 2013 · External reference

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy

10.1212/wnl.0000000000002418 · 2016 · External reference

Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy

10.1093/brain/aww189 · 2016 · External reference

Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy

10.1093/brain/awx124 · 2017 · External reference

Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia

10.1093/brain/awv054 · 2015 · External reference

Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis

10.1371/journal.pone.0281156 · 2023 · External reference

Chronic inflammatory demyelinating polyneuropathy with concurrent membranous nephropathy: an anti-paranode and podocyte protein antibody study and literature survey

10.3389/fneur.2018.00997 · 2018 · External reference

Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy

10.1016/j.kint.2021.08.014 · 2021 · External reference

Anti-contactin 1 antibody-associated membranous nephropathy in chronic inflammatory demyelinating polyneuropathy with several autoantibodies

10.2169/internalmedicine.2126-23 · 2024 · External reference

Neuro-renal syndrome related to anti-contactin-1 antibodies

10.1002/mus.26392 · 2019 · External reference

Characteristics of anti-Contactin1 antibody-associated autoimmune Nodopathies with concomitant membranous nephropathy

10.3389/fimmu.2021.759187 · 2021 · External reference

Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study

10.1007/s00415-023-11759-2 · 2023 · External reference

Autoimmune nodopathies, an emerging diagnostic category

10.1097/wco.0000000000001107 · 2022 · External reference

Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort

10.1136/jnnp-2023-331378 · 2023 · External reference

CIDP-like autoimmune nodopathy complicated with focal segmental glomerulosclerosis: a case study and literature review

10.1007/s00415-022-11369-4 · 2023 · External reference

Proteinuria is a key to suspect autoimmune nodopathies

10.1111/ene.16406 · 2024 · External reference

Case report: pediatric age onset CNTN1 antibody-associated neuropathy with nephropathy and literature review

10.3389/fimmu.2025.1549363 · 2025 · External reference

CIDP/autoimmune nodopathies with nephropathy: a case series study

10.1002/acn3.51754 · 2023 · External reference

Chronic inflammatory demyelinating polyneuropathy and concurrent membranous nephropathy associated with anti-Contactin-1 autoantibodies: a rare case report with a review of the literature

10.7759/cureus.83975 · 2025 · External reference

2019 European league against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

10.1136/annrheumdis-2018-214819 · 2019 · External reference

An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management

10.7759/cureus.30330 · 2022 · External reference